These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19246370)

  • 1. Levodopa for Parkinson's disease.
    Devos D; Moreau C; Destée A
    N Engl J Med; 2009 Feb; 360(9):935-6; author reply 936. PubMed ID: 19246370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy for patients with progressive Parkinson's disease].
    Murata M
    Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1432-7. PubMed ID: 13677891
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary.
    Olanow CW; Godbold JH; Koller W
    BMJ; 1996 Mar; 312(7032):702-3; author reply 704-5. PubMed ID: 8597746
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum vitamin B(12) and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion.
    Santos-García D; Macías M; Llaneza M; Grande M; de la Fuente-Fernández R
    Mov Disord; 2011 Feb; 26(3):558-9. PubMed ID: 20960480
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical treatment of Parkinson's disease.
    Ahlskog JE
    Compr Ther; 1989 Mar; 15(3):53-9. PubMed ID: 2650977
    [No Abstract]   [Full Text] [Related]  

  • 6. Welcome news about levodopa, but uncertainty remains.
    Fahn S
    Ann Neurol; 1998 May; 43(5):551-4. PubMed ID: 9585348
    [No Abstract]   [Full Text] [Related]  

  • 7. Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease.
    Syed N; Murphy J; Zimmerman T; Mark MH; Sage JI
    Mov Disord; 1998 Mar; 13(2):336-8. PubMed ID: 9539350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson's disease?
    Shahrizaila N; Mahamad UA; Yap AC; Choo YM; Marras C; Lim SY
    Parkinsonism Relat Disord; 2013 Mar; 19(3):391-3. PubMed ID: 23146348
    [No Abstract]   [Full Text] [Related]  

  • 9. Why delaying levodopa is a good treatment strategy in early Parkinson's disease.
    Olanow CW; Stocchi F
    Eur J Neurol; 2000 May; 7 Suppl 1():3-8. PubMed ID: 11054152
    [No Abstract]   [Full Text] [Related]  

  • 10. [Melanoma while using levodopa due to Parkinson's disease--causal association unlikely].
    Wobbes T; Bonenkamp JJ
    Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1286-8. PubMed ID: 12138675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First emergence of "delayed-on" and "dose failure" phenomena in a patient with Parkinson's disease following vagotomy.
    Djaldetti R; Achiron A; Ziv I; Melamed E
    Mov Disord; 1994 Sep; 9(5):582-3. PubMed ID: 7990855
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Parkinson's disease.
    Eadie MJ
    Aust Fam Physician; 1995 Sep; 24(9):1685-7, 1690-2. PubMed ID: 7487655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to modify levodopa treatment.
    Widner H
    Adv Neurol; 2003; 91():229-36. PubMed ID: 12442681
    [No Abstract]   [Full Text] [Related]  

  • 14. Deep brain stimulation in Parkinson's disease: opposite effects of stimulation in the pallidum.
    Bejjani BP; Damier P; Arnulf I; Papadopoulos S; Bonnet AM; Vidailhet M; Agid Y; Pidoux B; Cornu P; Dormont D; Marsault C
    Mov Disord; 1998 Nov; 13(6):969-70. PubMed ID: 9827624
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacotherapy of Parkinson's disease].
    Ceballos-Baumann A
    MMW Fortschr Med; 2013 May; 155(8):49-51. PubMed ID: 24437138
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multivariate analysis of the problems of long-term levodopa therapy in Parkinson's disease].
    Nakamura Y; Yoshinaga J; Endo S; Hikiji A
    Rinsho Shinkeigaku; 1997 Jun; 37(6):469-75. PubMed ID: 9366172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Levodopa dependency in Parkinson's disease: case report and review].
    Müller U; Reuter M; Hermann W; Gertz HJ
    Nervenarzt; 2002 Sep; 73(9):887-91. PubMed ID: 12215883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Parkinson's disease.
    Bergus G
    J Fam Pract; 1996 May; 42(5):457-8. PubMed ID: 8642360
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
    Avanzi M; Uber E; Bonfà F
    Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Duodenal levodopa infusion for advanced Parkinson's disease in Finland 2006-2010].
    Pursiainen V; Pekkonen E
    Duodecim; 2012; 128(16):1707-15. PubMed ID: 23025155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.